NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Selloff Creates Buying Opportunities in Financial Sector

The West Asia conflict has triggered a sharp market selloff, causing a decline in the financial sector. However, Sanjeev Prasad, Managing Director and Co-Head at Kotak Institutional Equities, believes that the financial sector remains one of the few pockets where valuations have turned more attractive.

From a valuation perspective, a single quarter typically contributes only a small portion to a company's fair value, with 1-3% of the total value. The market's response to near-term news can lead to dislocation in stock prices, creating opportunities for investors. Prasad believes that the sharp correction in financial stocks may present a buying opportunity, as many financial names have sold off aggressively despite no significant changes in their fundamentals.

In contrast, several other sectors continue to trade at stretched valuations despite the recent correction. Consumer companies still trade at elevated multiples, with many staple companies trading at 40-60 times earnings despite modest growth. Auto stocks have corrected, but valuations remain relatively rich, with most companies trading at 20 times earnings. The market's response to affordability concerns may not sustain demand beyond the next 2-3 quarters. Capital goods companies also continue to trade at steep valuations, with many good quality stocks trading at 40 times earnings.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

In contrast, technology and pharma companies have held up relatively well in the recent market volatility. IT services stocks had already corrected earlier due to concerns around artificial intelligence and long-term growth prospects, while pharma stocks tend to remain resilient during periods of market stress.

The current correction has not yet created a broad-based buying opportunity across the market. According to Prasad, the current environment is far from the deep valuation resets seen during events such as the Global Financial Crisis or the early weeks of the COVID-19 pandemic, when markets offered much stronger entry points for investors.

Investor Takeaway

Investors may find opportunities in the financial sector due to attractive valuations.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.